Curcumin Analog DM-1 in Monotherapy or Combinatory Treatment with Dacarbazine as a Strategy to Inhibit In Vivo Melanoma Progression

• Fernanda Faião-Flores ,

  * E-mail: fernandafaiao@usp.br (FFF); durvanei@usp.br (DAM)

  Affiliation Department of Clinical Chemistry & Toxicology, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil

  ⨯
• José Agustín Quincoces Suarez,

  Affiliation Laboratory of Organic Synthesis, Anhanguera University of São Paulo, UNIAN, São Paulo, Brazil

  ⨯
• Andréa Costa Fruet,

  Affiliation Department of Clinical Chemistry & Toxicology, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil

  ⨯
• Silvya Stuchi Maria-Engler,

  Affiliation Department of Clinical Chemistry & Toxicology, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil

  ⨯
• Paulo Celso Pardi,

  Affiliation Laboratory of Experimental Pathology, Anhanguera University of São Paulo, UNIAN, São Paulo, Brazil

  ⨯
• Durvanei Augusto Maria

  * E-mail: fernandafaiao@usp.br (FFF); durvanei@usp.br (DAM)

  Affiliation Laboratory of Biochemistry and Biophysics, Butantan Institute, São Paulo, Brazil

  ⨯